Invention Grant
- Patent Title: Oligomeric compounds comprising bicyclic nucleosides and uses thereof
-
Application No.: US14435109Application Date: 2013-10-11
-
Publication No.: US09695418B2Publication Date: 2017-07-04
- Inventor: Punit P. Seth , Susan M. Freier , Brett P. Monia , Eric E. Swayze
- Applicant: Ionis Pharmaceuticals, Inc.
- Applicant Address: US CA Carlsbad
- Assignee: Ionis Pharmaceuticals, Inc.
- Current Assignee: Ionis Pharmaceuticals, Inc.
- Current Assignee Address: US CA Carlsbad
- Agency: Ionis Pharmaceuticals, Inc. Patent Dept.
- International Application: PCT/US2013/064660 WO 20131011
- International Announcement: WO2014/059353 WO 20140417
- Main IPC: C07H21/04
- IPC: C07H21/04 ; C12N15/113 ; C12N15/11

Abstract:
The present invention provides oligomeric compounds. Certain such oligomeric compounds are useful for hybridizing to a complementary nucleic acid, including but not limited, to nucleic acids in a cell. In certain embodiments, hybridization results in modulation of the amount activity or expression of the target nucleic acid in a cell. In certain embodiments, the present invention provides compounds comprising oligonucleotides. In certain embodiments, such oligonucleotides comprise a region having a gapmer sugar motif. In certain embodiments, oligonucleotides comprise one or more type of modified sugar moieties and/or naturally occurring sugar moieties arranged along an oligonucleotide or region thereof in a defined pattern or sugar modification motif.
Public/Granted literature
- US20150267195A1 OLIGOMERIC COMPOUNDS COMPRISING BICYCLIC NUCLEOSIDES AND USES THEREOF Public/Granted day:2015-09-24
Information query